- United States
- /
- Chemicals
- /
- OTCPK:AMRS.Q
The Independent Director of Amyris, Inc. (NASDAQ:AMRS), L. Doerr, Just Bought 25% More Shares
Those following along with Amyris, Inc. (NASDAQ:AMRS) will no doubt be intrigued by the recent purchase of shares by L. Doerr, Independent Director of the company, who spent a stonking US$30m on stock at an average price of US$2.87. Aside from being a solid chunk in its own right, the deft move also saw their holding increase by some 25%.
See our latest analysis for Amyris
Amyris Insider Transactions Over The Last Year
In fact, the recent purchase by L. Doerr was the biggest purchase of Amyris shares made by an insider individual in the last twelve months, according to our records. That implies that an insider found the current price of US$3.15 per share to be enticing. That means they have been optimistic about the company in the past, though they may have changed their mind. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for Amyris share holders is that an insider was buying at near the current price. L. Doerr was the only individual insider to buy over the year.
L. Doerr purchased 20.07m shares over the year. The average price per share was US$3.19. You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.
Insider Ownership
For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 23% of Amyris shares, worth about US$78m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
So What Do The Amyris Insider Transactions Indicate?
The recent insider purchase is heartening. And the longer term insider transactions also give us confidence. But we don't feel the same about the fact the company is making losses. When combined with notable insider ownership, these factors suggest Amyris insiders are well aligned, and that they may think the share price is too low. Therefore, you should should definitely take a look at this FREE report showing analyst forecasts for Amyris.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.
About OTCPK:AMRS.Q
Amyris
Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally.
Slightly overvalued with weak fundamentals.
Similar Companies
Market Insights
Community Narratives
